Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Soleno Therapeutics (SLNO) Inventory Average (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Inventory Average for 4 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory Average changed N/A to $4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.5 million, a N/A change, with the full-year FY2015 number at $330172.0, changed N/A from a year prior.
  • Inventory Average was $4.5 million for Q3 2025 at Soleno Therapeutics, up from $509500.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $4.5 million in Q3 2025 to a low of $4.5 million in Q3 2025.